|
Volumn 56, Issue 3, 2001, Pages 223-226
|
Chitosan based pentazocine microspheres for intranasal systemic delivery: Development and biopharmaceutical evaluation
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CHITOSAN;
MICROSPHERE;
OIL;
PENTAZOCINE;
POLYMER;
ANIMAL EXPERIMENT;
ARTICLE;
BIOCOMPATIBILITY;
CANCER PAIN;
CHRONIC PAIN;
CONTROLLED DRUG RELEASE;
CONTROLLED STUDY;
DIFFUSION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG DELIVERY SYSTEM;
DRUG FORMULATION;
DRUG SCREENING;
DRUG SYNTHESIS;
FEMALE;
FIRST PASS EFFECT;
IN VITRO STUDY;
IN VIVO STUDY;
INJECTION;
INJURY;
MALE;
NONHUMAN;
PARTICLE SIZE;
POSTOPERATIVE PAIN;
ADHESIVENESS;
ADMINISTRATION, INTRANASAL;
ANALGESICS, OPIOID;
ANIMALS;
BIOPHARMACEUTICS;
CHITIN;
CHITOSAN;
DRUG DELIVERY SYSTEMS;
EXCIPIENTS;
KINETICS;
MICROSPHERES;
PARTICLE SIZE;
PENTAZOCINE;
RABBITS;
SOLUBILITY;
|
EID: 0035098467
PISSN: 00317144
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (61)
|
References (20)
|